Antiphospholipid Antibodies: Their Origin and Development
AbstractAntiphospholipid antibodies (aPL) are a hallmark of the antiphospholipid syndrome (APS), which is the most commonly acquired thrombophilia. To date there is consensus that aPL cause the clinical manifestations of this potentially devastating disorder. However, there is good evidence that not all aPL are pathogenic. For instance, aPL associated with syphilis show no association with the manifestations of APS. While there has been intensive research on the pathogenetic role of aPL, comparably little is known about the origin and development of aPL. This review will summarize the current knowledge and understanding of the origin and development of aPL derived from animal and human studies. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Lackner, K.J.; Müller-Calleja, N. Antiphospholipid Antibodies: Their Origin and Development. Antibodies 2016, 5, 15.
Lackner KJ, Müller-Calleja N. Antiphospholipid Antibodies: Their Origin and Development. Antibodies. 2016; 5(2):15.Chicago/Turabian Style
Lackner, Karl J.; Müller-Calleja, Nadine. 2016. "Antiphospholipid Antibodies: Their Origin and Development." Antibodies 5, no. 2: 15.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.